Organization and Basis of Presentation (Details) |
Sep. 24, 2024 |
Dec. 15, 2023 |
|---|---|---|
| Organization and Basis of Presentation [Line Items] | ||
| Reverse stock split ratio description | the Company effected a reverse stock split of all shares of its issued and outstanding Common Stock at a ratio of one-for-forty (1:40). | |
| Onconetix, Inc. [Member] | ||
| Organization and Basis of Presentation [Line Items] | ||
| Subsidiary owned, percentage | 100.00% | |
| Proteomedix [Member] | ||
| Organization and Basis of Presentation [Line Items] | ||
| Subsidiary owned, percentage | 100.00% |